Tumor-suppressive and promoting function of transforming growth factor beta

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Transforming growth factor beta (TGFbeta) is a key signaling molecule with complex roles in cancer.
• Its function shifts from tumor suppression in early stages to tumor promotion in advanced cancers.
• Tumor cells can develop resistance to TGFbeta's inhibitory effects, altering its signaling pathway.

Purpose of the Study:

• To explore the dual role of TGFbeta in carcinogenesis.
• To understand how TGFbeta signaling contributes to tumor progression, invasion, angiogenesis, and metastasis.
• To investigate the potential of TGFbeta antagonists in cancer therapy.

Main Methods:

• Review of existing literature on TGFbeta's role in various cancer stages.
• Analysis of studies investigating TGFbeta signaling in tumor stroma and cells.
• Examination of research on the efficacy of TGFbeta antagonists in preclinical models.

Main Results:

• TGFbeta initially inhibits tumor growth via cell cycle arrest and apoptosis.
• In later stages, TGFbeta promotes invasion, angiogenesis, and metastasis.
• Antagonizing TGFbeta has shown promise in inhibiting tumor progression, particularly metastasis, in certain models.

Conclusions:

• TGFbeta's role in cancer is context-dependent, switching from suppressor to promoter.
• TGFbeta signaling contributes to hallmarks of advanced cancer, including immune evasion and metastasis.
• Further research is needed to identify biomarkers for predicting TGFbeta antagonist efficacy in cancer treatment.